Top Markets
Coin of the day
Zenas BioPharma, Inc. Zenas BioPharma, Inc.

Zenas BioPharma, Inc.

ZBIO
Hisse Senetlerindeki Sıralama #6354
Zenas BioPharma, Inc. functions as a clinical-stage biopharmaceutical firm,... Zenas BioPharma, Inc. functions as a clinical-stage biopharmaceutical firm, concentrating on the creation and market introduction of innovative, immunology-based treatments. The company's primary investigational therapy is obexelimab, a distinctive bifunctional monoclonal antibody intended to address multiple diseases such as immunoglobulin G4-related disease, multiple sclerosis, systemic lupus erythematosus, and warm autoimmune hemolytic anemia. Its developmental portfolio also features ZB002, an anti-TNFa monoclonal antibody; ZB004, a cytotoxic T-lymphocyte-associated antigen 4-immunoglobulin fusion; ZB001, an anti-insulin-like growth factor-1 receptor monoclonal antibody; and ZB005, an anti-active complement component 1s monoclonal antibody. Established in 2019, the entity was formerly recognized as Zenas BioPharma (Cayman) Limited before adopting its current name, Zenas BioPharma, Inc., in August 2023. Its headquarters are located in Waltham, Massachusetts.
Hisse Fiyatı
$33.00
Piyasa Değeri
$2.08B
Değişim (1 gün)
-0.12%
Değişim (1 yıl)
97.49%
Ülke
US
Ticaret Zenas BioPharma, Inc. (ZBIO)

Kategori

Zenas BioPharma, Inc. (ZBIO) için hisse senedi fiyat geçmişi
Gün sonu en yüksek fiyat: $31.75 - 2026-08-01

Gün sonu en düşük fiyat: $17.96 - 2024-09-01
Zenas BioPharma, Inc. için hisse fiyatı geçmişi: 2024 - 2026
Yıllık Hisse Fiyatı Performansı
Yıl Performans
2026 (TTM) -33.58%
2025 294.97%
2024 0.00%
Benzer şirketler veya rakiplerin hisse fiyatı
Şirket Hisse fiyatı Değişim 1yıl% Ülke
$548.36 40.94%
US
$1.06K 49.46%
NL
$122.63 -12.65%
AU
$140.81 461.00%
US
$765.25 7.19%
CH